InsidersTradesSigma
Track the 杏林製薬株式会社 stock price and the full management transaction log of the company, a publicly traded company based in Japan. Shares are listed on the JP market, under the authority of EDINET (Japan FSA). Operating in the Health Care sector, 杏林製薬株式会社 has logged 11 insider filings. Market capitalisation: €63.7bn. The latest transaction was reported on 5 August 2026 (Holding update). Among the most active insiders: Kopernik Global Investers, LLC. Every trade is free.
Analysts rate 杏林製薬株式会社 Underperform (bearish), based on 1 analysts. Average price target: JP¥1,100.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
11 of 11 declarations
杏林製薬株式会社 is a Japanese company specializing in the health and pharmaceutical sector. It is listed on the XTKS market.